Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Synaptic vesicle cycle (mmu04721)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
Ap2a1
KLA  ATP  ATP+KLA
 NM_007458 adaptor protein complex AP-2, alpha 1 subunit (Ap2a1), transcript variant 1, mRNA [NM_007458] KLA .92 1.14 1.16 .91 1.06 1.21 1.21
ATP 1.24 1.66 .77 1.57 1.08 .88 1.32
KLA/ATP 1.36 1.16 .56 1.31 .71 1.02 1.46
Ap2a2
KLA  ATP  ATP+KLA
 NM_007459 adaptor protein complex AP-2, alpha 2 subunit (Ap2a2), mRNA [NM_007459] KLA .89 .90 .92 .77 .91 .83 .86
ATP 1.14 1.15 .86 1.08 .78 .53 1.29
KLA/ATP .94 .98 .67 .85 .54 .51 .99
Ap2b1
KLA  ATP  ATP+KLA
 AK030505 adult male pituitary gland cDNA, RIKEN full-length enriched library, clone:5330422K01 product:adaptor-related protein complex 2, beta 1 subunit, full insert sequence. [AK030505] KLA 1.84 1.44 1.49 1.36 1.58 1.21 1.05
ATP .78 .61 .53 .74 1.81 1.99 1.09
KLA/ATP 1.32 1.13 .92 1.01 2.31 1.59 1.18
Ap2b1
KLA  ATP  ATP+KLA
 NM_001035854 adaptor-related protein complex 2, beta 1 subunit (Ap2b1), transcript variant 1, mRNA [NM_001035854] KLA 2.27 2.24 2.05 2.41 2.07 2.26 1.93
ATP .91 .89 1.02 1.00 .92 2.14 3.06
KLA/ATP 1.94 2.11 2.16 1.95 1.67 1.61 4.01
Ap2m1
KLA  ATP  ATP+KLA
 AK141862 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130035H06 product:adaptor protein complex AP-2, mu1, full insert sequence [AK141862] KLA .80 .69 .92 .86 .81 .97 .67
ATP 1.09 .73 .91 .85 2.29 1.04 .60
KLA/ATP .87 .60 .76 .96 2.66 .86 .59
Ap2m1
KLA  ATP  ATP+KLA
 NM_009679 adaptor protein complex AP-2, mu1 (Ap2m1), mRNA [NM_009679] KLA .81 .86 .90 .77 .88 .92 1.12
ATP 1.06 1.28 .69 .98 .77 .64 1.24
KLA/ATP 1.00 1.03 .51 .87 .54 .67 1.01
Ap2s1
KLA  ATP  ATP+KLA
 NM_198613 adaptor-related protein complex 2, sigma 1 subunit (Ap2s1), mRNA [NM_198613] KLA .91 .94 .95 .87 .96 .98 .82
ATP 1.01 1.09 .66 .94 .67 .64 1.39
KLA/ATP 1.05 1.02 .67 .97 .69 .82 1.19
Atp6v0a1
KLA  ATP  ATP+KLA
 AK045877 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230316H04 product:unclassifiable, full insert sequence [AK045877] KLA .65 .64 .58 .48 .57 .46 .29
ATP .64 .28 .48 .28 .45 .30 .91
KLA/ATP .51 .26 .37 .31 .54 .45 .63
Atp6v0a1
KLA  ATP  ATP+KLA
 NM_016920 ATPase, H+ transporting, lysosomal V0 subunit A1 (Atp6v0a1), mRNA [NM_016920] KLA .88 .91 .88 .80 .66 .52 .45
ATP 1.05 1.22 .91 1.05 .58 .40 1.46
KLA/ATP .97 1.04 .80 .89 .55 .43 .75
Atp6v0a2
KLA  ATP  ATP+KLA
 AK160318 16 days embryo lung cDNA, RIKEN full-length enriched library, clone:8430408C20 product:unclassifiable, full insert sequence [AK160318] KLA 1.21 1.13 1.18 1.30 1.39 1.58 1.38
ATP 1.10 .94 .55 .35 .72 .96 .84
KLA/ATP 1.12 1.08 .82 .54 .81 1.05 .59
Atp6v0a2
KLA  ATP  ATP+KLA
 BC112905 ATPase, H+ transporting, lysosomal V0 subunit A2, mRNA (cDNA clone MGC:118073 IMAGE:3670722), complete cds [BC112905] KLA 1.65 1.66 1.74 2.07 1.97 2.78 2.71
ATP .88 .61 .53 .30 .38 1.26 2.12
KLA/ATP 1.38 1.29 .91 .62 .59 1.36 2.13
Atp6v0a2
KLA  ATP  ATP+KLA
 NM_011596 ATPase, H+ transporting, lysosomal V0 subunit A2 (Atp6v0a2), mRNA [NM_011596] KLA 2.26 2.07 2.01 2.71 2.48 3.69 2.76
ATP .79 .64 .62 .42 .62 2.31 3.11
KLA/ATP 1.69 1.57 1.47 .90 1.06 2.56 4.84
Atp6v0a4
KLA  ATP  ATP+KLA
 NM_080467 ATPase, H+ transporting, lysosomal V0 subunit A4 (Atp6v0a4), mRNA [NM_080467] KLA 1.01 1.00 .99 1.03 1.01 1.02 .98
ATP 1.02 1.05 .93 1.03 1.05 1.01 .97
KLA/ATP 1.02 .94 1.00 .99 1.00 1.01 1.03
Atp6v0b
KLA  ATP  ATP+KLA
 NM_033617 ATPase, H+ transporting, lysosomal V0 subunit B (Atp6v0b), mRNA [NM_033617] KLA .91 1.00 1.07 .81 1.25 1.34 1.44
ATP 1.12 1.33 .80 1.41 1.47 1.67 1.77
KLA/ATP 1.20 1.16 .62 1.28 1.01 1.77 2.37
Atp6v0c
KLA  ATP  ATP+KLA
 NM_009729 ATPase, H+ transporting, lysosomal V0 subunit C (Atp6v0c), mRNA [NM_009729] KLA .89 .98 1.05 .90 1.18 1.38 1.52
ATP 1.07 1.28 .93 1.66 1.48 1.35 2.35
KLA/ATP 1.10 1.12 .67 1.50 1.18 1.66 2.51
Atp6v0d1
KLA  ATP  ATP+KLA
 NM_013477 ATPase, H+ transporting, lysosomal V0 subunit D1 (Atp6v0d1), mRNA [NM_013477] KLA .84 .85 .94 .79 1.10 1.24 1.27
ATP 1.18 1.48 .94 1.40 1.12 .75 1.85
KLA/ATP 1.05 1.06 .59 1.06 .83 .85 1.96
Atp6v0d2
KLA  ATP  ATP+KLA
 NM_175406 ATPase, H+ transporting, lysosomal V0 subunit D2 (Atp6v0d2), mRNA [NM_175406] KLA .77 .72 .64 .54 .43 .27 .18
ATP 1.19 1.35 1.06 1.47 1.46 .79 .96
KLA/ATP .78 .95 .63 1.12 1.21 1.01 .50
Atp6v0e
KLA  ATP  ATP+KLA
 AK134836 adult male medulla oblongata cDNA, RIKEN full-length enriched library, clone:6330589P19 product:ATPase, H+ transporting, V0 subunit, full insert sequence. [AK134836] KLA 1.09 1.06 1.02 1.42 1.32 1.14 .92
ATP .93 1.18 1.02 1.34 1.72 1.34 1.44
KLA/ATP .97 .89 .94 1.32 2.01 1.43 1.72
Atp6v0e
KLA  ATP  ATP+KLA
 NM_025272 ATPase, H+ transporting, lysosomal V0 subunit E (Atp6v0e), mRNA [NM_025272] KLA 1.00 .95 .87 .99 .98 1.20 1.26
ATP .91 .98 1.11 1.17 1.29 1.54 1.59
KLA/ATP .86 .94 1.07 1.05 1.29 1.57 1.83
Atp6v0e2
KLA  ATP  ATP+KLA
 NM_133764 ATPase, H+ transporting, lysosomal V0 subunit E2 (Atp6v0e2), mRNA [NM_133764] KLA .98 .93 .90 .99 .88 .90 .92
ATP 1.08 1.02 1.03 1.07 .98 .88 .94
KLA/ATP .98 .99 .97 1.00 .89 .90 .88
Atp6v1a
KLA  ATP  ATP+KLA
 NM_007508 ATPase, H+ transporting, lysosomal V1 subunit A (Atp6v1a), mRNA [NM_007508] KLA .77 .77 .70 .59 .58 .61 .84
ATP 1.04 1.45 .99 1.82 1.34 1.00 1.21
KLA/ATP .82 .97 .55 1.13 .73 .99 1.09
Atp6v1b1
KLA  ATP  ATP+KLA
 NM_134157 ATPase, H+ transporting, lysosomal V1 subunit B1 (Atp6v1b1), mRNA [NM_134157] KLA 1.00 1.03 1.11 .95 1.01 1.00 1.03
ATP 1.02 1.05 1.01 .97 1.02 .97 1.02
KLA/ATP .98 .94 1.03 1.02 .99 1.00 .96
Atp6v1b2
KLA  ATP  ATP+KLA
 NM_007509 ATPase, H+ transporting, lysosomal V1 subunit B2 (Atp6v1b2), mRNA [NM_007509] KLA .89 .98 1.11 1.07 1.24 1.13 1.12
ATP 1.05 1.11 1.02 1.09 1.03 .79 1.39
KLA/ATP .97 1.05 .95 1.12 1.12 1.37 1.67
Atp6v1c1
KLA  ATP  ATP+KLA
 NM_025494 ATPase, H+ transporting, lysosomal V1 subunit C1 (Atp6v1c1), mRNA [NM_025494] KLA .61 .62 .59 .51 .56 .71 .92
ATP .98 .97 .93 1.07 1.42 1.00 1.28
KLA/ATP .61 .57 .48 .57 1.04 1.18 1.18
Atp6v1c2
KLA  ATP  ATP+KLA
 NM_133699 ATPase, H+ transporting, lysosomal V1 subunit C2 (Atp6v1c2), mRNA [NM_133699] KLA 1.00 .93 .98 .97 1.04 .99 .97
ATP 1.07 .97 .99 .97 .97 1.04 1.06
KLA/ATP 1.01 1.03 1.00 1.03 1.00 .91 .97
Atp6v1d
KLA  ATP  ATP+KLA
 NM_023721 ATPase, H+ transporting, lysosomal V1 subunit D (Atp6v1d), mRNA [NM_023721] KLA 1.45 1.39 1.73 1.95 1.83 2.08 1.29
ATP .91 .88 1.19 1.12 1.73 1.64 2.34
KLA/ATP 1.25 1.32 1.80 1.46 2.05 2.00 2.22
Atp6v1e1
KLA  ATP  ATP+KLA
 NM_007510 VATPase, H+ transporting, lysosomal V1 subunit E1 (Atp6v1e1), mRNA [NM_007510] KLA 1.48 1.55 1.79 1.73 1.79 1.59 1.37
ATP .88 .73 .59 .73 1.30 1.59 1.40
KLA/ATP 1.50 1.43 1.24 1.30 1.57 1.69 1.76
Atp6v1e2
KLA  ATP  ATP+KLA
 NM_029121 ATPase, H+ transporting, lysosomal V1 subunit E2 (Atp6v1e2), mRNA [NM_029121] KLA 1.01 1.04 1.11 1.14 1.19 1.15 1.11
ATP 1.00 .97 1.11 1.06 1.07 1.02 1.08
KLA/ATP 1.03 1.10 1.19 1.10 1.13 1.06 1.09
Atp6v1f
KLA  ATP  ATP+KLA
 NM_025381 ATPase, H+ transporting, lysosomal V1 subunit F (Atp6v1f), mRNA [NM_025381] KLA .92 .94 .93 .96 .96 1.02 1.05
ATP .97 .96 1.07 1.18 1.31 1.16 1.11
KLA/ATP .92 .96 1.06 1.12 1.28 1.24 1.14
Atp6v1g1
KLA  ATP  ATP+KLA
 NM_024173 ATPase, H+ transporting, lysosomal V1 subunit G1 (Atp6v1g1), mRNA [NM_024173] KLA .97 .94 .87 .99 .98 1.01 .96
ATP 1.02 1.02 1.09 1.10 1.29 1.23 1.41
KLA/ATP .83 .92 1.12 1.10 1.23 1.04 .97
Atp6v1g2
KLA  ATP  ATP+KLA
 NM_023179 ATPase, H+ transporting, lysosomal V1 subunit G2 (Atp6v1g2), mRNA [NM_023179] KLA 1.12 1.09 1.03 1.05 1.16 1.15 1.01
ATP .96 1.01 .93 1.06 .85 .83 1.05
KLA/ATP 1.04 1.07 .99 1.07 .90 .82 .98
Atp6v1g3
KLA  ATP  ATP+KLA
 NM_177397 ATPase, H+ transporting, lysosomal V1 subunit G3 (Atp6v1g3), mRNA [NM_177397] KLA 1.05 1.03 1.00 .99 .97 1.02 1.00
ATP 1.04 1.07 1.02 .98 1.05 1.00 1.00
KLA/ATP .99 .98 1.01 1.02 1.03 1.01 1.05
Atp6v1h
KLA  ATP  ATP+KLA
 AK081492 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130021C16 product:hypothetical V-ATPase subunit H containing protein, full insert sequence. [AK081492] KLA 1.09 .98 .77 .93 1.08 1.00 1.10
ATP 1.16 1.43 2.03 3.91 3.02 1.23 1.46
KLA/ATP 1.02 .98 1.06 2.30 2.07 1.28 1.06
Atp6v1h
KLA  ATP  ATP+KLA
 NM_133826 ATPase, H+ transporting, lysosomal V1 subunit H (Atp6v1h), mRNA [NM_133826] KLA 1.13 1.15 1.12 1.05 1.05 .96 1.20
ATP 1.04 1.04 .86 1.06 2.07 2.38 1.90
KLA/ATP 1.14 1.17 .98 1.09 1.55 2.06 1.29
Cacna1a
KLA  ATP  ATP+KLA
 NM_007578 calcium channel, voltage-dependent, P/Q type, alpha 1A subunit (Cacna1a), mRNA [NM_007578] KLA .71 .66 .61 .63 .60 .71 .72
ATP 1.07 1.04 .89 1.08 .71 .56 .75
KLA/ATP .71 .72 .85 .69 .64 .63 .68
Cacna1b
KLA  ATP  ATP+KLA
 U04999 N-type calcium channel alpha1 subunit mRNA, complete cds [U04999] KLA .94 .94 .95 .88 1.09 .85 .92
ATP 1.06 1.17 1.00 1.24 1.59 1.15 1.17
KLA/ATP .91 .91 .95 .95 .90 .97 1.01
Clta
KLA  ATP  ATP+KLA
 AK035903 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630016K07 product:unclassifiable, full insert sequence [AK035903] KLA 1.01 1.00 .97 1.02 1.01 1.12 1.09
ATP 1.04 .98 .91 1.05 1.02 1.01 .95
KLA/ATP 1.00 .99 .93 1.07 1.09 .98 .99
Clta
KLA  ATP  ATP+KLA
 NM_016760 clathrin, light polypeptide (Lca) (Clta), transcript variant 3, mRNA [NM_016760] KLA .68 .70 .75 .68 .70 .77 .55
ATP 1.06 1.05 .93 .97 .81 .60 .75
KLA/ATP .75 .76 .68 .71 .69 .64 .42
Cltb
KLA  ATP  ATP+KLA
 NM_028870 clathrin, light polypeptide (Lcb) (Cltb), mRNA [NM_028870] KLA .91 1.01 .97 .78 .71 .52 .73
ATP 1.15 1.32 1.07 1.72 1.96 1.94 1.31
KLA/ATP 1.07 1.17 .76 1.17 1.18 2.12 1.06
Cltc
KLA  ATP  ATP+KLA
 AK039453 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330045B10 product:CLATHRIN HEAVY CHAIN 1 (CLH-17) homolog [Homo sapiens], full insert sequence. [AK039453] KLA 1.07 1.00 1.01 1.00 1.03 1.06 1.02
ATP 1.00 .99 1.02 .97 1.00 1.02 1.00
KLA/ATP 1.01 1.01 1.02 .98 1.04 .98 .99
Cltc
KLA  ATP  ATP+KLA
 NM_001003908 clathrin, heavy polypeptide (Hc) (Cltc), mRNA [NM_001003908] KLA .94 1.00 .98 .89 1.18 1.02 .93
ATP 1.21 1.42 .72 .89 .93 .96 .75
KLA/ATP 1.12 1.21 .48 .72 .57 .87 .81
Cplx1
KLA  ATP  ATP+KLA
 NM_007756 complexin 1 (Cplx1), mRNA [NM_007756] KLA 1.01 1.01 .98 1.04 .99 1.01 1.00
ATP 1.02 .96 1.00 1.01 1.09 1.02 1.03
KLA/ATP 1.03 .97 1.16 1.01 1.01 1.23 1.07
Cplx2
KLA  ATP  ATP+KLA
 NM_009946 complexin 2 (Cplx2), mRNA [NM_009946] KLA 1.03 1.04 1.08 1.11 1.07 1.12 1.13
ATP 1.01 1.05 1.14 1.25 1.11 1.09 1.03
KLA/ATP 1.10 1.12 1.21 1.22 1.17 1.10 1.12
Cplx3
KLA  ATP  ATP+KLA
 NM_146223 complexin 3 (Cplx3), mRNA [NM_146223] KLA 1.05 1.03 1.00 1.00 .99 1.00 1.01
ATP .98 .97 .97 1.00 .97 1.02 1.01
KLA/ATP .98 1.00 1.00 .99 1.01 .97 .95
Cplx4
KLA  ATP  ATP+KLA
 NM_145493 complexin 4 (Cplx4), mRNA [NM_145493] KLA .99 .96 .99 .97 1.08 1.03 .99
ATP .99 1.04 1.02 .95 1.01 .98 .99
KLA/ATP 1.00 1.02 .99 .94 .95 .96 1.07
Dnm1
KLA  ATP  ATP+KLA
 NM_010065 dynamin 1 (Dnm1), mRNA [NM_010065] KLA .96 .92 .87 .88 .85 .79 1.16
ATP 1.05 1.08 .96 1.04 .93 .80 1.59
KLA/ATP .99 1.00 .82 .93 .79 .79 1.24
Dnm2
KLA  ATP  ATP+KLA
 NM_001039520 dynamin 2 (Dnm2), mRNA [NM_001039520] KLA 1.00 1.03 1.14 1.01 1.29 1.47 1.30
ATP 1.11 1.31 .93 1.41 1.04 .90 1.53
KLA/ATP 1.26 1.23 .87 1.41 .86 .98 1.86
Dnm3
KLA  ATP  ATP+KLA
 NM_001038619 dynamin 3 (Dnm3), mRNA [NM_001038619] KLA 1.00 1.01 1.02 1.02 1.03 .96 1.04
ATP 1.05 1.01 .99 .96 1.03 .97 .88
KLA/ATP 1.03 1.05 1.03 .99 .98 1.02 1.03
Mm.29002
6
KLA  ATP  ATP+KLA
 146141141 Unknown KLA .86 .76 .74 .94 .70 .57 .57
ATP 1.05 .94 1.16 1.33 2.13 2.57 1.15
KLA/ATP .74 .84 1.09 1.07 1.49 2.42 1.05
Mm.41035
KLA  ATP  ATP+KLA
 124487216 Unknown KLA .96 .96 .99 .99 1.00 1.00 1.04
ATP .97 1.02 1.03 .96 1.03 .95 .98
KLA/ATP 1.01 1.05 1.03 .93 1.00 1.02 .96
Mm.4424
KLA  ATP  ATP+KLA
 110225367 Unknown KLA .99 .93 1.01 1.02 1.00 .92 1.00
ATP .98 1.03 3.11 1.13 1.19 1.03 1.11
KLA/ATP .95 .97 .97 .96 .93 1.01 .99
Mm.5195
KLA  ATP  ATP+KLA
 31542415 Unknown KLA 1.02 1.02 .97 1.02 .99 1.07 .99
ATP .98 .94 .96 1.04 1.05 1.08 1.02
KLA/ATP 1.06 1.02 .96 .99 1.10 1.45 1.12
Napa
KLA  ATP  ATP+KLA
 NM_025898 N-ethylmaleimide sensitive fusion protein attachment protein alpha (Napa), mRNA [NM_025898] KLA .77 .75 .71 .70 .72 .86 1.03
ATP .94 .99 1.12 1.27 1.08 .77 1.07
KLA/ATP .74 .75 .77 .92 1.01 .82 .93
Nsf
KLA  ATP  ATP+KLA
 NM_008740 N-ethylmaleimide sensitive fusion protein (Nsf), mRNA [NM_008740] KLA .84 .83 .76 .70 .78 .80 .94
ATP 1.14 1.15 .99 1.08 .95 .96 1.19
KLA/ATP .93 .90 .80 .85 .72 .80 1.17
Rab3a
KLA  ATP  ATP+KLA
 NM_009001 RAB3A, member RAS oncogene family (Rab3a), mRNA [NM_009001] KLA .28 .28 .44 .66 .92 .88 .84
ATP 1.15 1.23 1.30 .97 .30 .42 .87
KLA/ATP .29 .31 .40 .34 .57 .62 .63
Rims1
KLA  ATP  ATP+KLA
 AK220335 mRNA for mKIAA0340 protein [AK220335] KLA 1.05 .99 1.00 .98 1.05 1.08 1.05
ATP 1.02 .94 .99 1.01 1.00 1.05 1.01
KLA/ATP 1.03 .92 .98 1.05 .99 1.11 1.03
Rims1
KLA  ATP  ATP+KLA
 NM_001012625 regulating synaptic membrane exocytosis 1 (Rims1), transcript variant 5, mRNA [NM_001012625] KLA 1.00 .99 1.01 .99 .97 .93 .93
ATP .91 1.02 .95 .99 .96 .99 .89
KLA/ATP .95 1.07 .96 1.01 .93 .91 .87
Slc17a6
KLA  ATP  ATP+KLA
 NM_080853 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 (Slc17a6), mRNA [NM_080853] KLA .97 1.03 1.05 .98 1.02 1.06 1.08
ATP .98 1.00 .97 1.05 1.01 1.01 1.02
KLA/ATP 1.01 1.01 .96 1.02 .96 .98 .97
Slc17a7
KLA  ATP  ATP+KLA
 NM_182993 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 (Slc17a7), mRNA [NM_182993] KLA .98 1.03 1.00 1.01 1.04 1.02 .96
ATP .97 .97 1.06 1.05 .96 .97 1.02
KLA/ATP .95 1.02 .90 1.05 1.04 1.03 1.01
Slc17a8
KLA  ATP  ATP+KLA
 NM_182959 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 (Slc17a8), mRNA [NM_182959] KLA 1.18 1.13 1.21 1.14 1.21 1.09 1.11
ATP 1.02 .96 1.07 1.08 1.14 1.14 1.21
KLA/ATP 1.12 1.24 1.14 1.10 1.12 1.22 1.50
Slc18a1
KLA  ATP  ATP+KLA
 AK049514 7 days embryo whole body cDNA, RIKEN full-length enriched library, clone:C430018J19 product:CHROMAFFIN GRANULE AMINE TRANSPORTER (VESICULAR AMINE TRANSPORTER 1) (VAT1) homolog [Rattus norvegicus], full insert sequence. [AK049514] KLA 1.08 1.09 1.04 1.02 1.06 1.01 .99
ATP .98 .94 .98 .98 1.08 .98 1.03
KLA/ATP 1.01 .97 .94 1.06 1.03 1.01 1.24
Slc18a1
KLA  ATP  ATP+KLA
 NM_153054 solute carrier family 18 (vesicular monoamine), member 1 (Slc18a1), mRNA [NM_153054] KLA 1.13 1.10 1.33 1.27 1.37 1.41 1.56
ATP .86 .78 .83 .61 .70 .45 1.22
KLA/ATP .96 1.02 .92 .73 .94 .90 4.36
Slc18a2
KLA  ATP  ATP+KLA
 NM_172523 solute carrier family 18 (vesicular monoamine), member 2 (Slc18a2), mRNA [NM_172523] KLA .98 .97 .95 .94 .94 .99 .92
ATP .98 1.01 .96 .95 .96 .96 .98
KLA/ATP .91 .94 .91 .92 .96 .95 .93
Slc18a3
KLA  ATP  ATP+KLA
 NM_021712 solute carrier family 18 (vesicular monoamine), member 3 (Slc18a3), mRNA [NM_021712] KLA .91 1.00 1.02 .99 1.01 1.07 1.16
ATP 1.02 1.08 1.01 1.07 1.09 1.05 1.07
KLA/ATP 1.02 .98 1.04 1.19 1.09 1.08 1.04
Slc32a1
KLA  ATP  ATP+KLA
 NM_009508 solute carrier family 32 (GABA vesicular transporter), member 1 (Slc32a1), mRNA [NM_009508] KLA 1.11 1.01 1.06 1.10 1.07 1.05 1.04
ATP 1.03 .97 1.11 1.10 1.52 1.52 1.08
KLA/ATP 1.10 1.12 1.09 1.17 1.36 1.50 1.10
Snap25
KLA  ATP  ATP+KLA
 M22012 synaptosomal associated protein-25 (Snap25) mRNA, complete cds. [M22012] KLA 1.04 1.01 1.00 1.06 1.05 1.07 .99
ATP .98 1.00 .98 .93 .97 1.04 1.01
KLA/ATP .97 1.00 1.09 1.03 .95 .99 1.03
Snap25
KLA  ATP  ATP+KLA
 NM_011428 synaptosomal-associated protein 25 (Snap25), mRNA [NM_011428] KLA .99 1.00 .96 1.03 1.05 1.02 1.01
ATP .98 .99 1.01 1.06 1.02 1.09 .99
KLA/ATP .98 1.02 1.01 1.00 1.03 .98 1.07
Stx1a
KLA  ATP  ATP+KLA
 NM_016801 syntaxin 1A (brain) (Stx1a), mRNA [NM_016801] KLA .84 .77 .70 .80 .75 .71 .82
ATP 1.00 1.20 .92 .94 1.65 1.16 1.04
KLA/ATP .87 .76 .71 .82 1.14 .91 .88
Stx2
KLA  ATP  ATP+KLA
 NM_007941 syntaxin 2 (Stx2), mRNA [NM_007941] KLA 1.48 1.46 1.87 1.97 1.64 1.57 1.05
ATP .98 1.01 1.14 1.16 .89 .92 .92
KLA/ATP 1.38 1.60 1.85 1.80 2.06 2.42 2.70
Stx3
KLA  ATP  ATP+KLA
 AK137098 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430075B11 product:unclassifiable, full insert sequence. [AK137098] KLA .95 .87 .92 .89 .90 1.08 .98
ATP .94 1.00 .89 .91 .94 .97 .94
KLA/ATP .91 .97 .80 .76 .76 1.01 .78
Stx3
KLA  ATP  ATP+KLA
 NM_001025307 syntaxin 3 (Stx3), transcript variant B, mRNA [NM_001025307] KLA 1.02 1.02 1.29 1.22 1.18 1.29 1.12
ATP .95 .88 .84 .87 1.72 1.74 1.71
KLA/ATP 1.03 .91 .93 .86 1.37 2.24 2.36
Stx3
KLA  ATP  ATP+KLA
 NM_152220 syntaxin 3 (Stx3), transcript variant A, mRNA [NM_152220] KLA .97 .98 1.33 1.35 1.25 1.51 1.44
ATP 1.22 1.22 1.02 1.25 3.83 2.92 3.59
KLA/ATP 1.29 1.16 1.11 1.36 3.34 3.10 3.76
Stxbp1
KLA  ATP  ATP+KLA
 NM_009295 syntaxin binding protein 1 (Stxbp1), transcript variant 2, mRNA [NM_009295] KLA 2.48 2.53 2.92 3.22 2.45 1.81 1.35
ATP .86 .94 1.10 1.17 1.57 1.47 1.47
KLA/ATP 2.30 2.34 2.73 2.76 3.07 2.46 1.63
Syt1
KLA  ATP  ATP+KLA
 AK032444 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430547N07 product:unclassifiable, full insert sequence. [AK032444] KLA 1.04 .98 .98 1.04 .97 1.01 1.01
ATP 1.06 .98 .97 1.05 1.01 1.02 .96
KLA/ATP .98 1.01 .99 1.02 .99 1.00 1.08
Syt1
KLA  ATP  ATP+KLA
 NM_009306 synaptotagmin I (Syt1), mRNA [NM_009306] KLA 1.01 1.02 1.01 1.02 1.06 .99 1.00
ATP .99 1.03 1.02 1.00 1.00 1.02 1.03
KLA/ATP 1.00 1.01 1.04 1.02 1.00 .97 1.01
Tcirg1
KLA  ATP  ATP+KLA
 NM_016921 T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein A3 (Tcirg1), mRNA [NM_016921] KLA 1.32 1.42 1.49 1.38 1.94 2.26 1.98
ATP 1.01 1.16 .69 .96 1.24 1.32 2.03
KLA/ATP 1.50 1.58 .90 1.29 1.37 2.08 3.28
Unc13a
KLA  ATP  ATP+KLA
 AK147408 cDNA, RIKEN full-length enriched library, clone:M5C1034K04 product:Munc13-1 homolog [Rattus norvegicus], full insert sequence [AK147408] KLA .91 .82 .81 .77 .83 .88 .91
ATP .98 1.06 1.07 1.04 .78 .77 .88
KLA/ATP .90 .81 .82 .83 .71 .71 .87
Unc13a
KLA  ATP  ATP+KLA
 AK170263 NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630039C17 product:unclassifiable, full insert sequence. [AK170263] KLA .58 .55 .57 .63 .72 .71 .95
ATP .88 .91 1.20 1.17 .69 .79 1.44
KLA/ATP .55 .58 .65 .63 .66 .60 1.10
Unc13b
KLA  ATP  ATP+KLA
 AK039015 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230085L07 product:unc13 homolog (C. elegans) 1, full insert sequence. [AK039015] KLA 1.13 1.10 1.10 1.18 1.13 1.23 1.05
ATP 1.02 1.00 1.21 .99 .70 .68 .58
KLA/ATP 1.13 1.05 1.08 1.03 .75 .60 .41
Unc13b
KLA  ATP  ATP+KLA
 NM_001081413 unc-13 homolog B (C. elegans) (Unc13b), mRNA [NM_001081413] KLA .78 .78 .76 .84 .74 .84 .83
ATP .99 .91 .96 .86 .90 1.03 1.56
KLA/ATP .79 .73 .79 .78 .83 .93 .86
Unc13c
KLA  ATP  ATP+KLA
 NM_001081153 unc-13 homolog C (C. elegans) (Unc13c), mRNA [NM_001081153] KLA 1.05 1.00 .92 1.02 1.09 .99 .95
ATP 1.02 1.09 1.01 1.04 .95 1.04 .99
KLA/ATP 1.05 .97 1.05 .99 .98 1.00 .99
Vamp2
KLA  ATP  ATP+KLA
 NM_009497 vesicle-associated membrane protein 2 (Vamp2), mRNA [NM_009497] KLA .99 1.02 1.03 1.07 1.34 1.25 1.58
ATP 1.03 1.12 .88 1.22 .94 .99 1.62
KLA/ATP 1.03 1.15 .82 1.10 .87 .93 1.86